Clinical trial
Treatment of Idiopathic Clubfoot Utilizing Botulinum Toxin A: A New Treatment for Correction
NCT00152334 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Idiopathic Clubfoot Utilizing Botulinum Toxin A: A New Treatment for Correction
- Lead sponsor
- University of British Columbia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- October 31, 2018
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic clubfoot (talipes equinovarus)